L & L Bio Co., Ltd., Ningbo, China
4 clinical trials · Sponsor
◉ Watch L & L Bio Co., Ltd., Ningbo, China
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer (NCT07177716) | L & L Bio Co., Ltd., Ningbo, China | 2025-10-01 |
| A Study to Evaluate LB1410 in Combination With LB4330 in Patients With Advanced or Metastatic Solid Tumors (NCT06468358) | L & L Bio Co., Ltd., Ningbo, China | 2024-06-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LB4330 in Patients With Advanced Solid Tumors（MEETCD8-001） (NCT05707676) | L & L Bio Co., Ltd., Ningbo, China | 2022-11-30 |
| A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001） (NCT05357651) | L & L Bio Co., Ltd., Ningbo, China | 2022-08-12 |
Track L & L Bio Co., Ltd., Ningbo, China automatically
Every clearance here is in the API, with alerts when new ones post.